IP Library Granted Patent US 11,918,603
Granted Patent B2
US 11,918,603 · App. 17/268,256 · Granted Mar 5, 2024

Ocular lubricant formulations

Inventors: William Stringer (Portland, OR); Michael Hanrahan (Portland, OR); Patrick H. Witham (Portland, OR)
Assignee: Harrow IP, LLC
A61K31/79A61F9/0008A61K31/765A61K47/02A61K47/10A61K47/183A61K47/24A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,918,603
App. No.
17/268,256
Granted
Mar 5, 2024
Kind
B2
Abstract

Provided herein are formulations and compositions for ocular diseases or disorders such as dry eye disease. Further provided herein are methods for manufacturing ocular formulations and compositions.

Claims (47)

1. A composition stored in a dropper bottle, the composition consisting of:

(a) povidone;

(b) fully hydrolyzed polyvinyl alcohol;

(c) partially hydrolyzed polyvinyl alcohol;

(d) sodium chloride;

(e) boric acid;

(f) disodium edetate dihydrate;

(g) potassium chloride;

(h) glycerin;

(i) ethyl alcohol;

(j) lecithin;

(k) polysorbate 80;

(l) a pH adjusting agent; and

(m) water;

wherein the fully hydrolyzed polyvinyl alcohol has a molecular weight in a range of 20,000 to 200,000 daltons; the composition is an ophthalmic composition; and the composition is preservative free.

2. The composition of claim 1 , wherein a concentration of the povidone is 1% w/v to 5% w/v.

3. The composition of claim 1 , wherein a concentration of the fully hydrolyzed polyvinyl alcohol is 0.5% w/v to 5% w/v.

4. The composition of claim 1 , wherein a concentration of the partially hydrolyzed polyvinyl alcohol is 0.5% w/v to 5% w/v.

5. The composition of claim 1 , wherein a concentration of the fully hydrolyzed polyvinyl alcohol and the partially hydrolyzed polyvinyl alcohol is no more than 4% w/v.

6. The composition of claim 1 , wherein the fully hydrolyzed polyvinyl alcohol has a molecular weight in a range of 80,000 to 200,000 daltons.

7. The composition of claim 1 , wherein the partially hydrolyzed polyvinyl alcohol has a molecular weight in a range of 1,000 to 50,000 daltons.

8. The composition of claim 1 , wherein the pH adjusting agent is at least one selected from the group consisting of hydrochloric acid and sodium hydroxide.

9. The composition of claim 7 , wherein the partially hydrolyzed polyvinyl alcohol has a molecular weight in a range of 10,000 to 50,000 daltons.

10. The composition of claim 1 , wherein a concentration of sodium chloride is 0.1% w/v to 1% w/v.

11. The composition of claim 1 , wherein a concentration of boric acid is 0.1% w/v to 1% w/v.

12. The composition of claim 1 , wherein a concentration of disodium edetate dihydrate is 0.01% w/v to 1% w/v.

13. The composition of claim 1 , wherein a concentration of potassium chloride is 0.01% w/v to 1% w/v.

14. The composition of claim 1 , wherein a concentration of glycerin is 0.001% w/v to 1% w/v.

15. The composition of claim 1 , wherein a concentration of ethyl alcohol is 0.001% w/v to 0.5% w/v.

16. The composition of claim 1 , wherein a concentration of lecithin is 0.001% w/v to 0.5% w/v.

17. The composition of claim 1 , wherein a concentration of polysorbate 80 is 0.01% w/v to 1% w/v.

18. The composition of claim 1 , wherein

a concentration of the povidone is 1% w/v to 5% w/v;

a concentration of the fully hydrolyzed polyvinyl alcohol is 0.5% w/v to 5% w/v;

a concentration of the partially hydrolyzed polyvinyl alcohol is 0.5% w/v to 5% w/v;

a concentration of sodium chloride is 0.1% w/v to 1% w/v;

a concentration of boric acid is 0.1% w/v to 1% w/v;

a concentration of disodium edetate dihydrate is 0.01% w/v to 1% w/v;

a concentration of potassium chloride is 0.01% w/v to 1% w/v;

a concentration of glycerin is 0.001% w/v to 1% w/v;

a concentration of ethyl alcohol is 0.001% w/v to 0.5% w/v;

a concentration of lecithin is 0.001% w/v to 0.5% w/v; and

a concentration of polysorbate 80 is 0.01% w/v to 1% w/v.

19. The composition of claim 1 , wherein a pH of the composition is no more than 6.6.

20. The composition of claim 1 , wherein an osmolality of the composition is 200 mOsm/kg to 400 mOsm/kg.

21. The composition of claim 1 , wherein the dropper bottle comprises a squeezable container provided with a tapered dispenser that terminates in a discharge aperture.

22. The composition of claim 21 , wherein the dropper bottle has a volume of 10 mL.

Assignments (5)
SECURITY INTEREST Recorded Sep 26, 2025
From: HARROW, INC.; HARROW IP, LLC
To: FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 072384/0781 →
RELEASE OF SECURITY INTEREST Recorded Sep 17, 2025
From: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
To: HARROW IP, LLC
Reel/Frame 072280/0573 →
SUPPLEMENTAL PATENT SECURITY AGREEMENT (FIRST SUPPLEMENTAL FILING) Recorded Aug 18, 2023
From: HARROW IP, LLC
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 064640/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2023
From: EYEVANCE PHARMACEUTICALS LLC
To: HARROW IP, LLC
Reel/Frame 064468/0450 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2022
From: STRINGER, WILLIAM; HANRAHAN, MICHAEL; WITHAM, PATRICK H.
To: EYEVANCE PHARMACEUTICALS LLC
Reel/Frame 058646/0859 →
Continuity (2)
Provisional Application 62725152 · Aug 30, 2018
Related Publication 20210315924A1 · Oct 14, 2021